SUBSCRIBE: Print / eNewsletter
Final Results of 9-Valent HPV Vaccine Show Extended Cancer Protection
Final results of the trial that led to FDA approval show that a new 9-valent HPV vaccine can reduce cases of HPV and cervical cancer.
Many Women Willing to Extend Cervical Cancer Screening Intervals
Women in routine gynecologic care expressed willingness to extend screening intervals and use cytology alone or Pap-HPV cotesting if recommended by a physician.
New HPV Vaccine Could Prevent 90% of Cervical Cancers
A new human papillomavirus (HPV) vaccine that protects against nine types of HPV and would protect against about 90% of cervical cancers could be available in 2015.
Cervical Cancer Screening Guideline Update
In light of the recent FDA approval of HPV testing for women as a screening method for cervical cancer, we discuss changing guidelines with two experts.
FDA Approves HPV Test for Primary Cervical Cancer Screening
The FDA has approved an HPV DNA test to be used as a primary screening method for cervical cancer in women 25 and older. The test can also give insight into future risk of cervical cancer.
FDA Panel: HPV Test Can Replace Pap for Cervical Cancer Screening
An FDA panel has recommended that a DNA test that screens for HPV in women can replace the standard Pap smear as a first-line primary cervical cancer screening test.